Cargando…

The Association between Baseline Proton Pump Inhibitors, Immune Checkpoint Inhibitors, and Chemotherapy: A Systematic Review with Network Meta-Analysis

SIMPLE SUMMARY: Proton pump inhibitors (PPIs) are the most commonly used gastric acid suppressants in cancer patients. However, long-term use of PPIs can cause dysbiosis effects disrupting gut microbiota with subsequent impairment of the effectiveness of immune checkpoint inhibitors (ICIs). Our stud...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chang, Yu, Lin, Wan-Ying, Chang, Yu-Cheng, Huang, Chin-Hsuan, Tzeng, Huey-En, Abdul-Lattif, Eahab, Wang, Tsu-Hsien, Tseng, Tzu-Hsuan, Kang, Yi-No, Chi, Kuan-Yu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818995/ https://www.ncbi.nlm.nih.gov/pubmed/36612290 http://dx.doi.org/10.3390/cancers15010284

Ejemplares similares

Do proton pump inhibitors affect the effectiveness of chemotherapy in colorectal cancer patients? A systematic review with meta-analysis
por: Lin, Wan-Ying, et al.
Publicado: (2022)

The Association between Proton Pump Inhibitors and the Effectiveness of CDK Inhibitors in HR+/HER- Advanced Breast Cancer Patients: A Systematic Review and Meta-Analysis
por: Chang, Yu-Cheng, et al.
Publicado: (2023)

Proton Pump Inhibitor Use and Risk of Gastric Cancer: Current Evidence from Epidemiological Studies and Critical Appraisal
por: Poly, Tahmina Nasrin, et al.
Publicado: (2022)

Proton pump inhibitors and colorectal cancer: A systematic review
por: Patel, Agastya, et al.
Publicado: (2021)

Impact of proton-pump inhibitors on the efficacy of immune checkpoint inhibitors in non-small cell lung cancer: A systematic review and meta-analysis
por: Dar, Sophia, et al.
Publicado: (2022)

Immune checkpoint inhibitors and their interaction with proton pump inhibitors–related interstitial nephritis
por: Miao, Jing, et al.
Publicado: (2023)

Proton pump inhibitors and risk of periampullary cancers—A nested case–control study
por: Chien, Li‐Nien, et al.
Publicado: (2015)

The Use of Proton Pump Inhibitors and COVID-19: A Systematic Review and Meta-Analysis
por: Fatima, Kaneez, et al.
Publicado: (2022)

Long-term Proton Pump Inhibitor Administration Caused Physiological and Microbiota Changes in Rats
por: Yang, Yu-Chen S. H., et al.
Publicado: (2020)

Proton Pump Inhibitor-unresponsive Laryngeal Symptoms Are Associated With Psychological Comorbidities and Sleep Disturbance: A Manometry and Impedance-pH Monitoring Study
por: Tseng, Wen-Hsuan, et al.
Publicado: (2023)

Proton pump inhibitor use increases hepatic encephalopathy risk: A systematic review and meta-analysis
por: Ma, Yun-Jie, et al.
Publicado: (2019)

Paradoxical relationship between proton pump inhibitors and COVID-19: A systematic review and meta-analysis
por: Zippi, Maddalena, et al.
Publicado: (2021)

The Impact of Concomitant Proton Pump Inhibitors on Immunotherapy Efficacy among Patients with Urothelial Carcinoma: A Meta-Analysis
por: Rizzo, Alessandro, et al.
Publicado: (2022)

Impact of Antibiotics and Proton Pump Inhibitors on Efficacy and Tolerance of Anti-PD-1 Immune Checkpoint Inhibitors
por: Giordan, Quentin, et al.
Publicado: (2021)

Proton Pump Inhibitors Increase the Risk of Autoimmune Diseases: A Nationwide Cohort Study
por: Lin, Sheng-Hong, et al.
Publicado: (2021)

Proton Pumps: Molecular Mechanisms, Inhibitors and Activators of Proton Pumping
por: Siletsky, Sergey A.
Publicado: (2023)

Gastrointestinal symptoms associated with gastroesophageal reflux disease, and their relapses after treatment with proton pump inhibitors: A systematic review
por: Hosseini, Mousalreza, et al.
Publicado: (2017)

Proton Pump Inhibitors and Gastritis
por: Suzuki, Masayuki, et al.
Publicado: (2008)

Proton pump inhibitors and gastroenteritis
por: Hassing, Robert-Jan, et al.
Publicado: (2016)

Deprescribing proton pump inhibitors
por: Teh, Kim Jun Kevin, et al.
Publicado: (2023)

Effects of concomitant proton pump inhibitor use on immune checkpoint inhibitor efficacy among patients with advanced cancer
por: Qin, Bao-Dong, et al.
Publicado: (2021)

Do proton pump inhibitors alter the response to immune checkpoint inhibitors in cancer patients? A meta-analysis
por: Lopes, Sébastien, et al.
Publicado: (2023)

Can Esophageal Baseline Impedance Predict Proton Pump Inhibitor Response in Gastroesophageal Reflux Disease?
por: Jung, Kyoungwon, et al.
Publicado: (2018)

Role of Checkpoint Inhibitors in the Management of Gastroesophageal Cancers
por: Karim, Frederic, et al.
Publicado: (2023)

The effect of proton pump inhibitor uses on outcomes for cancer patients treated with immune checkpoint inhibitors: a meta-analysis
por: Li, Chao, et al.
Publicado: (2020)

Effect of proton pump inhibitors on mortality of cirrhotic patients with pneumonia
por: Hung, Tsung-Hsing, et al.
Publicado: (2019)

Immune Checkpoint Inhibitors Induced Hepatotoxicity; Gastroenterologists’ Perspectives
por: Farshidpour, Maham, et al.
Publicado: (2022)

Long-Term Usage of Proton Pump Inhibitors Associated with Prognosis in Patients with Colorectal Cancer
por: Wu, Chin-Chia, et al.
Publicado: (2023)

Pharmacokinetics and Pharmacodynamics of the Proton Pump Inhibitors
por: Shin, Jai Moo, et al.
Publicado: (2013)

Proton pump inhibitors and hypomagnesemia monitoring
por: Lemon, Thomas I
Publicado: (2013)

Use and overuse of proton pump inhibitors
por: Staiano, Annamaria, et al.
Publicado: (2015)

Symptomatic hypomagnesemia and proton pump inhibitors
por: Tin, Sim Sai, et al.
Publicado: (2014)

Esophageal Baseline Impedance Reflects Mucosal Integrity and Predicts Symptomatic Outcome With Proton Pump Inhibitor Treatment
por: Xie, Chenxi, et al.
Publicado: (2018)

Risk of bias in non-randomized observational studies assessing the relationship between proton-pump inhibitors and adverse kidney outcomes: a systematic review
por: Rajan, Pradeep, et al.
Publicado: (2022)

Efficacy and Safety of Domperidone in Combination with Proton Pump Inhibitors in Gastroesophageal Reflux Disease: A Systematic Review and Meta-Analysis of Randomised Controlled Trials
por: Zamani, Nur Fathurah, et al.
Publicado: (2022)

Effect of long-term proton pump inhibitor administration on gastric mucosal atrophy: A meta-analysis
por: Li, Zhong, et al.
Publicado: (2017)

Clinicopathological Features of Kidney Injury Related to Immune Checkpoint Inhibitors: A Systematic Review
por: Xu, Ling-Yi, et al.
Publicado: (2023)

Impact of perioperative α1-antagonists on postoperative urinary retention in orthopaedic surgery: meta-analysis
por: Huang, Yun-Ting, et al.
Publicado: (2023)

Association Between Proton Pump Inhibitors and Asthma: A Population-Based Cohort Study
por: Wang, Yao-Tung, et al.
Publicado: (2020)

The Correlation between the Use of the Proton Pump Inhibitor and the Clinical Efficacy of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer
por: Hu, Da-Hai, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7ho1bgdimlhltcuvmj4s9ba27a